HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FATTY ACID BIOSYNTHESIS FOR BACTERIAL INFECTIONS
申请人:Vitas Pharma Research Private Limited
公开号:EP3330269A1
公开(公告)日:2018-06-06
The present invention relates to novel heterocyclic compounds which specifically inhibit bacterial Fab I and can be used for the treatment of staphylococcal infections.
[EN] HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FATTY ACID BIOSYNTHESIS FOR BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES EN TANT QU'INHIBITEURS DE LA BIOSYNTHÈSE D'ACIDE GRAS POUR DES INFECTIONS BACTÉRIENNES